 |
市場調查報告書
商品編碼
1441341
全球生物銀行市場規模、佔有率、成長分析（按類型、樣本、應用）- 2023-2030 年產業預測Global Biobanking Market Size, Share, Growth Analysis, By Type(Population-based Biobanks, Disease-based Biobanks), By Sample(Blood Products, Cell Lines), By Application(Drug Discovery, Genomic Research) - Industry Forecast 2023-2030 |
||||||
2022年全球生物銀行市場規模將為695億美元，從2023年的720億美元成長到2031年的955億美元，預測期間（2024-2031年）年複合成長率為6.8，預計將成長%。
近年來，由於對體育、生物醫學研究和個體化醫療的需求不斷成長，全球生物銀行市場顯著成長。生物銀行對於生物樣本的管理和保存至關重要，支持藥物開發、疾病研究和基因組學的進步。慢性病盛行率的增加以及研究所需的大規模模式收集也推動了市場的成長。另一方面，也存在一些挑戰，例如道德考慮、標準挑戰以及生物銀行基礎設施的高昂成本。
北美因其強大的研究、基礎設施和醫療保健方面的高支出而成為該地區的市場領導。主要特點包括專注於擴大圖案覆蓋範圍以及更好地結合維護和搜尋綠色圖案的技術。隨著精準醫療和生物標記發現需求的增加，生物銀行市場預計將穩定成長。
全球生物銀行市場區隔分析
全球生物銀行市場的四個主要部分是生物樣本庫類型、樣本類型、應用和區域。依類型分為學術生物庫、醫院生物庫、人群生物庫和疾病生物庫。樣本類型可分為生物流體、人體組織、細胞株、核酸、血液製品等。依應用不同，可分為疾病研究、再生醫學、個人化醫學、基因體研究、藥物開發等。市場依地理位置分為北美、歐洲、亞太地區、拉丁美洲、中東和非洲。
全球生物銀行市場的促進因素
對生物銀行服務的需求主要是活性化的，特別是在基因組學和個人化醫療領域。臨床試驗所需的大規模樣本採集和慢性病盛行率的增加是推動市場成長的另外兩個因素。人們日益認知到生物銀行在促進科學理解、藥物發現和疾病研究方面的潛力，也刺激了全球對生物銀行服務的接受度。在精準醫學進步的基本驅動力和生物標記發現日益重要的推動下，生物銀行產業預計將繼續成長。
全球生物銀行市場的限制
圍繞著生物樣本收集和儲存的倫理問題，特別是有關同意和隱私的問題，是一項重大挑戰，也是主要的市場限制之一。不同生物樣本庫和地區之間的標準化問題會抑制資料交換和互通性，從而降低合作研究計劃的有效性。另一個障礙是建造和維護生物銀行基礎設施的成本高昂，這對小型研究機構尤其不利。此外，考慮到長期儲存樣品的永續性以及樣品劣化的可能性，需要嚴格的品管程序。
全球生物銀行市場趨勢
人們擴大使用區塊鏈和自動化樣本儲存系統等最尖端科技來提高生物銀行業務的安全性和效率。此外，人們越來越重視檔案樣本人群的多樣化並包括不同的人口群體，以提供更全面和更具代表性的研究結果。另一項關鍵創新是人工智慧 (AI) 和機器學習的整合，用於資料分析和解釋，從而能夠從儲存的生物樣本中獲得更深入的見解。
目錄
執行摘要
- 市場概況
- 命運之輪
調查方法
- 資訊採購
- 次要/一級資訊來源
- 市場規模估算
- 市場假設與限制
母市場分析
- 市場概況
- 市場規模
- 市場動態
- 促進因素
- 機會
- 抑制因素
- 任務
主要市場考察
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- 智慧財產權分析
- 貿易分析
- Start-Ups分析
- 原料分析
- 創新矩陣
- 研發線產品分析
- 總體經濟指標
- 主要投資分析
- 關鍵成功因素
- 競爭程度
市場動態及展望
- 市場動態
- 促進因素
- 機會
- 抑制因素
- 任務
- 監管形勢
- 波特的分析
- 對未來中斷的特殊考慮
全球生物銀行市場：按類型
- 市場概況
- 基於人群的生物樣本庫
- 基於疾病的生物樣本庫
- 學術生物樣本庫
- 醫院生物樣本庫
- 其他
全球生物銀行庫市場：按樣本
- 市場概況
- 血液製品
- 細胞株
- 核酸
- 人體組織
- 生物體液
- 其他
全球生物銀行市場：依應用分類
- 市場概況
- 藥物發現
- 基因組調查
- 個人化醫療
- 再生醫學
- 疾病調查
- 其他
全球生物銀行市場規模：按地區分類
- 市場概況
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
- 拉丁美洲
- 巴西
- 其他拉丁美洲地區
- 中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區
競爭形勢
- 前5名企業對比
- 主要企業市場定位（2021年）
- 主要市場參與者所採取的策略
- 關鍵成功策略
- 近期市集活動
- 主要企業市場佔有率（2021年）
主要企業簡介
- AMS Biotechnology（Europe）Ltd.
- ASKION GmbH
- Avantor, Inc.
- Azenta, Inc.（Azenta）
- Bay Biosciences LLC
- BioIVT & Elevating Science
- Boca Biolistics
- CTI Biotech
- Cureline Inc.
- Firalis SA
- Geneticist Inc.
- Hamilton Bonaduz AG
- Isenet Biobanking
- Merck & Co., Inc.
- ProteoGenex Inc.
- Qiagen NV
- Stemcell Holdings, Inc.
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific Inc.
- US Biolab Corp. Inc.
Global Biobanking Market size was valued at USD 69.5 billion in 2022 and is poised to grow from USD 72 billion in 2023 to USD 95.5 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031)
The global biobanking market has grown significantly in recent years because to the rise in sports, biomedical research, and the need for customized care. Biobanks are essential for managing and preserving biological samples, which helps advance medication development, disease research, and genomics. The increasing prevalence of chronic illnesses and the need for large-scale pattern collecting for research studies also drive market growth. On the other hand, challenging circumstances include ethical considerations, challenges related to standards, and the exorbitant cost of biobanking infrastructure.
North America is the market leader in its region because of its strong research, well-developed infrastructure, and large spending in healthcare. Important characteristics include an emphasis on expanding pattern range and combining better technology for green pattern maintenance and retrieval. The market for biobanking is expected to grow steadily as demand for precision medicine and biomarker discovery increases.
Global Biobanking Market Market Segmental Analysis
The four main segments of the global biobanking market are biobank type, sample type, application, and geography. It is separated into several categories according to kind, including academic biobanks, hospital-based biobanks, population-based biobanks, and disease-based biobanks. It is divided into two categories according to the type of sample: biofluids, human tissues, cell lines, nucleic acids, blood products, and others. It is divided into several categories according to its use, including illness research, regenerative medicine, personalized medicine, genomics, and drug development. The market is divided into North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa based on geographic factors.
Drivers of the Global Biobanking Market
The need for biobanking services is mostly driven by the rise in biomedical research activities, especially in the fields of genomics and personalized medicine. The requirement for large-scale sample collection for clinical trials and the increasing prevalence of chronic diseases are two other factors driving the market's growth. Global acceptance of biobanking services is also fueled by the increased recognition of the potential of biobanks to advance scientific understanding, drug discovery, and disease research. The biobanking industry is anticipated to continue growing due to the basic drivers of precision medicine's ongoing evolution and the growing significance of biomarker discovery.
Restraints in the Global Biobanking Market Market
The ethical issues surrounding the collection and storage of biological samples, particularly those pertaining to consent and privacy, provide a substantial difficulty and are one of the primary market limitations. Standardization problems between various biobanks and geographical areas might impede data exchange and interoperability, which reduces the efficacy of cooperative research projects. Another barrier is the high expense of setting up and keeping up biobanking infrastructure, which is particularly detrimental to smaller research institutes. Furthermore, strict quality control procedures are required due to worries about the sustainability of samples that are kept for an extended period of time and the possibility of sample deterioration.
Market Trends of the Global Biobanking Market
the growing use of cutting-edge technology to improve the security and efficiency of biobanking operations, such as blockchain and automated sample storage systems. Furthermore, in order to provide more inclusive and representative research outputs, there is an increasing emphasis on diversifying stored sample populations to include a range of demographic groups. Another important innovation that is enabling greater in-depth insights from stored biological samples is the integration of artificial intelligence (AI) and machine learning for data analysis and interpretation.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Biobanking Market by Type
- Market Overview
- Population-based Biobanks
- Disease-based Biobanks
- Academic Biobanks
- Hospital-based Biobanks
- and Others
Global Biobanking Market by Sample
- Market Overview
- Blood Products
- Cell Lines
- Nucleic Acids
- Human Tissues
- Biofluids
- and Others
Global Biobanking Market by Application
- Market Overview
- Drug Discovery
- Genomic Research
- Personalized Medicine
- Regenerative Medicine
- Disease Research
- and Others
Global Biobanking Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- AMS Biotechnology (Europe) Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ASKION GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Avantor, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Azenta, Inc. (Azenta)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bay Biosciences LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioIVT & Elevating Science
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boca Biolistics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CTI Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cureline Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Firalis SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Geneticist Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hamilton Bonaduz AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Isenet Biobanking
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ProteoGenex Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen NV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stemcell Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- STEMCELL Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- US Biolab Corp. Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
生物樣本庫市場 - 全球產業規模、佔有率、趨勢、競爭、機會和預測，按類型、樣本類型、應用、最終用戶、地區和競爭細分，2019-2029F
生物樣本庫設備市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品、應用（再生醫學、藥物發現等）、地區和競爭細分，2019-2029F
生物樣本庫市場：2024-2034
生物銀行市場 – 2024 年至 2029 年預測
醫療檢體追蹤系統市場：按產品、技術、類型和最終用途分類 - 2024-2030 年全球預測
生物樣本庫市場規模、佔有率、趨勢分析報告：按產品、生物檢體類型、生物樣本庫類型、服務、應用、地區、細分市場預測，2024-2030
生物銀行設備市場：按產品類型、按樣品類型、按應用、按最終用戶、按地區
生物樣本庫市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測
生物樣本庫市場：按產品、樣本類型、儲存類型、應用和最終用戶 - 2023-2030 年全球預測
生物樣本庫市場報告：至2030年的趨勢、預測與競爭分析